19 results on '"Mok, Tony"'
Search Results
2. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non–small cell lung cancer
3. Novel targeted agents for the treatment of lung cancer in China
4. Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients
5. A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma
6. Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
7. Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer
8. Maintenance therapy in nonsmall-cell lung cancer: A new treatment paradigm
9. Increased Inducible Nitric Oxide Synthase in Lung Carcinoma of Smokers
10. A phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma
11. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma
12. A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma
13. Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung
14. Application of the International Prognostic Index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma
15. A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma
16. Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
17. Increased inducible nitric oxide synthase in lung carcinoma of smokers
18. A Phase III study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma
19. Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.